References
- Al-Dabbagh S. C., Idle J. R., Smith R. L. Animal modeling of human polymorphic drug oxidation, the metabolism of debrisoquine and phenacetin in rat inbred strains. Journal Pharmacy and Pharmacology 1981; 33: 161–164
- Ayesh R., Idle J. R., Richtie J. C., Crothers M. J., Hetzel M. R. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 1984; 312: 169–170
- Bendele A. M., Carlton W. W., Krogh P., Lillehoj E. B. Ochratoxin A carcinogenesis in B6C3F1 mouse. Journal National Cancer Institute 1985; 75: 733–739
- Castegnaro M., Chernozemsky I. N., Bartsch H. Meeting report: endemic nephropathy and urinary tract tumours in the Balkans. Cancer Research 1987; 47: 3608–3609
- Hietanen E., Bartsch H., Castegnaro M., Malaveille C., Michelon J., Broussolle L. Use of antibodies (Ab) against cytochrome P-450 isozymes to study genetic polymorphism in drug oxidation. Journal de Pharmacie Clinique 1985; 4: 71–78
- Hietanen E., Malaveille C., Camus A. M., Bereziat J.-C., Brun G., Castegnaro M., Michelon J., Idle J. R., Bartsch H. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drug Metabolism and Disposition 1986; 14: 118–126
- Idle J. R., Mahgoub A., Sloan T. P., Smith R. L., Moanefo C. O., Bababunmi E. A. Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Letters 1981; 11: 331–338
- Krogh P., Nesheim S. Ochratoxin A. Environmental Carcinogens—Selected Methods of Analysis Some Mycotoxins, L. Stolloff, M. Castegnaro, P. Scott, I. K. O'Neill, H. Bartsch. International Agency for Research on Cancer, Lyon 1982; Vol. 5: 247–253
- Nikolov I. G. Concept of poor and extensive metabolizers, Abstract 3305. Abstracts of Lectures, Symposium and Free Communications, 14th International Cancer Congress, Budapest, August, 1986. Karger, Basel, 21–27, Volume 3, page 858
- Petkova-Bocharova T., Castegnaro M. Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Additives and Contaminants 1985; 2: 267–270
- Petkova-Bocharova T., Chernozemsky I., Castegnaro M. Ochratoxin A in human blood in relation to endemic nephropathy and urinary system tumours in Bulgaria. Food Additives and Contaminants 1988; 5(3)229–301
- Richtie J. C., Crothers M. J., Idle L. R., Grieg J. B., Connors T. A., Nikolov I. G., Chernozemsky I. N. Evidence for an inherited metabolic susceptibility to endemic (Balkan) nephropathy. Proceedings of the 5th Symposium on Endemic Balkan Nephropathy, S. Strahinie, V. Stefanovic. NIS, Sofia 1983; 23
- Wolff T., Distlerath L. M., Worthington M. T., Groopman J. D., Hammons G. J., Kadlubar F. F., Prough R. A., Martin M. M., Guengerich F. P. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Research 1985; 45: 2116–2122
- Wolff T., Strecker M. Lack of relationship between debrisoquine 4-hydroxylation and other cytochrome P-450 dependent reactions in rat and human liver. Biochemical Pharmacology 1985; 34: 2593–2598